Logotipo do repositório

Bergamot by-product, a source of biogenic amines, reduces hypertension induced by high sugar-fat diet

dc.contributor.authorBelin, Matheus Antônio Filiol
dc.contributor.authorSiqueira, Juliana Silva
dc.contributor.authorVieira, Taynara Aparecid [UNESP]
dc.contributor.authorGrandini, Núbia Alves
dc.contributor.authorPalacio, Thiago Luiz Novag [UNESP]
dc.contributor.authorMaia, Erika Tiemi Nakandakare
dc.contributor.authorCampos, Dijon Henrique Salomé De
dc.contributor.authorFerron, Fabiane Valentini Francisqueti
dc.contributor.authorBombardelli, Ezio
dc.contributor.authorMinatel, Igor Otávio
dc.contributor.authorAldini, Giancarlo
dc.contributor.authorLima, Giuseppina Pace Pereira
dc.contributor.authorCamacho, Camila Renata Correa
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)pt
dc.date.accessioned2026-08-26T19:30:12Z
dc.date.issued2024-03-01
dc.description.abstractThe high-sugar fat diet (HSF) generates hypertension. Bergamot by-product (BBP) is a source of hydrophilic bioactive compounds. The aim was to test BBP administration against hypertension induced by the HSF. The 48 male Wistar rats were equally divided into 4 groups: control diet (C), C+BBP, HSF, and HSF+BBP. The BBP (250 mg/Kg) was administrated by gavage for 20 weeks. The total phenolic compounds, carotenoids, and antioxidant capacity of BBP were evaluated by spectrophotometry, and HPLC was used to evaluate the biogenic amines (BAs) profile. The animals' body weight (BW), caloric intake, glucose levels, superoxide dismutase activity, and systolic blood pressure (SBP) were measured at the final of the experiment. Results showed that BBP is a good source of bioactive compounds, such as phenolic compounds (15 ± 2.1 µg Gallic Acid Equivalents/mg, w-w) and flavonoids (5.09 ± 0.22 µg Quercetin Equivalents/mg, w-w), and has a high antioxidant capacity (5.35 ± 0.06 µg Trolox Equivalents (TE)/mg, w-w; 1.30 ± 0.14 µg TE/mg, and 2.54 ± 0.31 mM FeSO/mg), by three different methods). BBP contains the BA histamine (28.4 ± 3.1 µg/g, w-w), tyramine (6.39 ± 0.39 µg/g, w-w), tryptamine (186 ± 11 µg/g, w-w), putrescine (29.0 ± 4.4 µg/g, w-w), cadaverine (10.6 ± 0.8 µg/g, w-w), spermidine (34.8 ± 4.3 µg/g, w-w), spermine (2.28 ± 0.25 µg/g, w-w), serotonin (4.46 ± 0.77 µg/g, w-w), dopamine (2.50 ± 0.29 µg/g, w-w), and agmatine (140 ± 10 µg/g, w-w). BBP has remarkable levels of antioxidant BAs, such as spermidine (34.8 ± 4.3 µg/g, w-w) and agmatine (140 ± 10 µg/g, w-w). HSF increased BW (532 ± 72 g VS 474 ± 36 g (C), p<0.001), glucose levels (91.4 ± 6.2 mg/dL VS 80.9 ± 7.1 mg/dL (C), p<0.001) and SBP (146 ± 9 mmHg VS 121 ± 5 mmHg (C), p<0.001). BBP reduced hypertension generated by HSF (133 ± 9 mmHg VS 146 ± 9 mmHg, p<0.001), suggesting a direct hypotensive action. The synergy between the bioactive compounds identified in BBP demonstrates great potential for use to prevent and treat hypertension.
dc.description.affiliationDepartment of Pathology, Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil
dc.description.affiliationPlantexresearch Srl, Milan 20122, Italy
dc.description.affiliationDepartment of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-687, Brazil
dc.description.affiliationDepartment of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, Milan 20133, Italy
dc.description.affiliationUnespDepartment of Pathology, Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil
dc.description.affiliationUnespDepartment of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-687, Brazil
dc.identifierhttps://app.dimensions.ai/details/publication/pub.1169248274
dc.identifier.dimensionspub.1169248274
dc.identifier.doi10.1016/j.prenap.2024.100022
dc.identifier.issn2950-1997
dc.identifier.orcid0000-0002-1656-405X
dc.identifier.orcid0000-0003-3172-2199
dc.identifier.orcid0000-0002-5312-0060
dc.identifier.orcid0000-0002-1696-4993
dc.identifier.orcid0000-0001-9568-7156
dc.identifier.orcid0000-0003-1253-001X
dc.identifier.orcid0000-0003-2910-4308
dc.identifier.orcid0000-0002-9922-2871
dc.identifier.orcid0000-0002-2355-6744
dc.identifier.orcid0000-0002-1792-2605
dc.identifier.orcid0000-0001-8493-5329
dc.identifier.orcid0000-0002-6915-4230
dc.identifier.urihttps://hdl.handle.net/11449/330255
dc.publisherElsevier
dc.relation.ispartofPharmacological Research - Natural Products; v. 2; p. 100022
dc.rights.accessRightsAcesso restritopt
dc.rights.sourceRightsclosed
dc.sourceDimensions
dc.titleBergamot by-product, a source of biogenic amines, reduces hypertension induced by high sugar-fat diet
dc.typeArtigopt
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublicationab63624f-c491-4ac7-bd2c-767f17ac838d
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Biociências, Botucatupt

Arquivos